MIR4715

Across TCGA pan-cancer cohorts, MIR4715 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR4715’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR4715 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR4715 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and HNSC are the cancer types where MIR4715 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4715 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	−0.433	.001	2	view →
LUSC	All	All	−0.366	<.001	2	view →
HNSC	Male	II,III,IV	+0.119	.045	2	view →
KIRP	All	All	−0.136	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR4715–LUAD

Open the LUAD breakdown →